Introduction
Aortic stenosis (AS) is present in up to 3% of patients > _75 years old 1 and in symptomatic patients, confers a mean survival of 1.8 years when medically managed. 2, 3 Several flow-gradient patterns of severe AS have been elucidated, 4 each with different management strategies because the degree of ventricular recovery after aortic valve replacement (AVR) and clinical outcomes differ. 5, 6 Among patients with an aortic valve area (AVA) < _1.0 cm 2 , specific subgroups include Stage D1: 'High-gradient AS' with a mean gradient (MG) > _40 mmHg or peak velocity (V max ) > _4 m/s; Stage D2: 'Classical low-flow, low-gradient (LF-LG) AS with reduced left ventricular ejection fraction' (LVEF) (MG <40 mmHg or V max <4 m/s with LVEF <50%); and Stage D3: 'LF-LG AS with normal LVEF or paradoxical low-flow AS' (MG <40 mmHg or V max < _4 m/s with LVEF > _50%). 4 Despite benefiting from AVR compared with medical therapy, patients with low-flow AS have the worst outcomes, but the reasons for this discrepancy are not fully elucidated.
In low-flow AS with or without a preserved LVEF (Stages D2 and D3), the reduced forward stroke volume may occur in the setting of severe concentric remodelling, diastolic dysfunction, reduced longitudinal myocardial shortening and atrial fibrillation. 7 These findings bear a striking resemblance to transthyretin cardiac amyloidosis (ATTR-CA), the most common cause of restrictive cardiomyopathy in older adults. 8 In ATTR-CA, extracellular deposition of fibrils composed of destabilized wild-type (ATTRwt) or mutant (ATTRm) transthyretin protein leads to diastolic dysfunction, arrhythmias, and clinical heart failure. 9 ATTRwt deposits have been reported in 25% of surgically removed heart valves from adults >80 years old. 10 Identifying ATTR-CA among patients with severe AS may be important as there are a number of disease modifying therapies for ATTR-CA in clinical trials. 9 Classically, a low electrocardiographic voltage-mass ratio (VMR) 11 and echocardiographic parameters [12] [13] [14] have characterized cardiac amyloidosis. Myocardial contraction fraction (MCF), a novel volumetric measure of myocardial shortening, may also be useful in identifying this disease. 15 However, these are not sufficiently sensitive or specific to know that cardiac amyloidosis is not being missed. Nuclear cardiac imaging with bone seeking radioisotopes such as technetium-99m pyrophosphate ( 99m Tc-PYP) have shown excellent diagnostic accuracy for ATTR-CA. [16] [17] [18] A recent multicentre international collaboration validated these radioisotopes for the non-invasive diagnosis of ATTR-CA, with a reported 100% specificity when combined with the absence of a monoclonal protein to rule out light-chain (AL) amyloid, the other major form of cardiac amyloidosis. 19 In this study, we used 99m
Tc-PYP cardiac imaging to examine elderly patients with severe AS undergoing transcatheter aortic valve replacement (TAVR) and determine the prevalence and phenotype of ATTR-CA non-invasively.
Methods

Study design and population
We prospectively recruited patients with severe calcific AS undergoing TAVR at Columbia University's Centre for Interventional Vascular Therapy between December 2014 and July 2016. Patients provided informed consent in accordance with Columbia's IRB. Inclusion criteria were patients > _65 years old with severe symptomatic AS. Exclusion criteria included patients with AS due to congenital or rheumatic heart disease, patients unable to provide informed consent or lie still for 10 min under the camera. Patients underwent transthoracic echocardiography with strain rate imaging at the time of TAVR evaluation and a 99m Tc-PYP scan within 30 days after TAVR. Echocardiographers and nuclear cardiologists were blinded to patients' clinical information.
Clinical and laboratory measures
Biochemistry analyses were measured prior to TAVR and included troponin I, brain natriuretic peptide (BNP), estimated glomerular filtration rate (eGFR), and modified body mass index (mBMI) [albumin x BMI] reflecting autonomic dysfunction and malabsorption. 20 In patients who scanned positive for ATTR-CA, we ruled out AL cardiac amyloid by a normal serum free light chain ratio (0.26-1.65) on Freelite assay and absence of an abnormal monoclonal band on immunofixation of serum or urine.
Technetium-99m pyrophosphate planar cardiac imaging for diagnosis of transthyretin cardiac amyloidosis
All patients underwent a 99m
Tc-PYP cardiac scan within 30 days after TAVR according to previously described technique 21 : myocardial tracer uptake was analysed using the semi-quantitative visual score (range 0-3) and quantitative heart-to-contralateral (H/CL) ratio of total counts in a region of interest (ROI) over the heart divided by counts in an identical size ROI over the contralateral chest to normalize for soft tissue and ribs. ATTR-CA was defined by diffuse Tc-PYP for diagnosis of ATTR-CA. 18 Echocardiography and speckle strain imaging Doppler echocardiography was performed using commercially available ultrasound systems at the time of TAVR evaluation. Standard measurements of cardiac size and function, and classification of LV geometry were performed per American Society of Echocardiography guidelines. 22 Pulse wave and tissue Doppler were used to assess diastolic and biventricular function in the apical four-chamber view. Average mitral annular s' was calculated from tissue Doppler at the lateral and septal mitral annulus. Myocardial contraction fraction was calculated as the ratio of stroke volume to myocardial volume, which were calculated from linear dimensions in the parasternal long-axis view. 15 Speckle strain imaging was performed using TomTec Image-ArenaTM software in patients with adequate endomyocardial border definition from transthoracic echocardiography in the 4-, 3-, and 2-chamber apical views. Regional longitudinal strain (LS) was determined in 17 segments of the LV as per ASE guidelines. 22 Global LS was calculated as the average LS of these 17 segments. Relative apical LS was calculated as average apical LS/[(average basal LS þ average mid LS)/ 2]. 13 The VMR was calculated as the ratio of electrocardiographic voltage by Sokolov Lyon criteria to the echocardiographically derived cross sectional area.
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Statistical analysis
Analyses were performed using Statistical Analysis Software (SAS) (v9. rank-sum tests compared continuous variables between patients with and without ATTR-CA. Two-sided P-values were used throughout all analyses. Univariable and multivariable logistic regressions evaluated for factors associated with the outcome of ATTR-CA. All non-collinear variables with P < 0.25 in univariable analysis were included in a multivariable regression model, and several model selection methods were employed (backward, forward, and stepwise). Internal validation of the final model was assessed using bootstrap method (1000 repetitions) with the optimism corrected C-statistic. 23 Using systolic or diastolic echocardiographic parameters as well as the VMR as diagnostic markers for ATTR-CA, we estimated and compared the area under the corresponding receiver operating curve (ROC) curve (C-statistic) with corresponding 95% confidence interval (CI). Reproducibility of echocardiographic strain rate imaging was assessed in terms of inter-and intra-observer variability using interclass correlation values for the global LS for a subset of subjects (n = 20).
Results
Patient population
The study population ( Table 1 ) included 151 patients. They were elderly (mean age 84 ± 6 years), 68% men, with severe cardiac symptoms (75% had New York Heart Association functional class >2) and frequent comorbid conditions. On average, cardiac biomarkers were elevated, troponin I 0.07 (0.02-0.22) ng/mL and BNP 305 (146-847) pg/mL, with mean LVEF 55 ± 15%.
Transthyretin cardiac amyloidosis prevalence and phenotype among patients undergoing transcatheter aortic valve replacement
Transthyretin cardiac amyloidosis was found in 24 subjects (16%, 95% CI 10-23%) ( Figure 1A , Table 1 ). Compared with patients without ATTR-CA, those with ATTR-CA were more likely to be male, with 22% of male subjects screening positive for ATTR-CA (95% CI 14-31%). Subjects with ATTR-CA had lower systolic blood pressure before TAVR and higher BNP but had no difference in troponin I, eGFR, or mBMI compared with subjects without ATTR-CA. With respect to conduction disease, patients with ATTR-CA also had lower VMR and higher incidence of right bundle branch block but did not have an increased need for placement of a permanent pacemaker after TAVR implantation compared with patients without ATTR-CA.
Echocardiographic features of transthyretin cardiac amyloidosis in transcatheter aortic valve replacement patients
Baseline echocardiographic assessment ( Table 2) showed patients with ATTR-CA had a similar AVA and a trend towards lower MG and lower peak velocity compared with subjects without ATTR-CA. A greater percentage of patients with ATTR-CA had heart failure with mid-range ejection fraction 24 (48% vs. 56%, P = 0.011) with lower average mitral annular S' (4.0 ± 1.1 vs. 6.6 ± 1.5 cm/s, P < 0.0001) and reduced MCF (26 ± 10 vs. 41 ± 16, P < 0.0001). In addition, they had a thicker interventricular septal wall (1.3 ± 0.3 vs. 1.1 ± 0.2 cm, P = 0.007), higher LV mass index (130 ± 44 vs. 98 ± 25 g/m 2 , P = 0.002), with lower stroke volume index (SVI) (30 ± 11 vs. 36 ± 10 mL/m 2 , P = 0.009) consistent with increased incidence of concentric hypertrophy (37.5% vs. 12.1%, P = 0.0009) (Figure 2) . Patients with ATTR-CA were nearly 3Â more likely to have low-flow low-gradient AS (Stage D2) (29.2% vs. 10.5%, P = 0.045) than patients without ATTR-CA. Patients with ATTR-CA had a higher E/A ratio [2.3 (1.10-3.10) vs. 0.9 (0.70-1.70), P = 0.001] and lower deceleration time [176 (144-198) vs. 257 (209-313) ms, P < 0.0001] consistent with grade III diastolic dysfunction. Strain rate imaging revealed more severe impairment in global LS in patients with ATTR-CA compared with patients without ATTR-CA (-12 vs. -16%, P = 0.007), which persisted throughout the LV basal, mid, and apical segments (Figure 3) . However, no significant difference in relative apical LS was observed in patients with and without ATTR-CA (0.98 vs. 0.98, P = 0.991). Corresponding bulls-eye plots of segmental strain revealed a patchy distribution of impaired LS consistent with severe AS. 13 Using logistic regression models, significant univariable predictors of ATTR-CA included older age, male gender, a higher natriuretic peptide level, a lower LVEF, increased left atrial dimension, an interventricular septal wall thickness of > _1.2 cm, a SVI <35 mL/m 2 , decreased MCF, a lower average mitral annular S' and higher E/A ratio ( Table 3) . In multivariable logistic regression using forward, backward, and step-wise selection models that considered all non-collinear significant univariable predictors of ATTR-CA, only average mitral annular S' remained significantly associated with ATTR-CA with odds ratio 5.0 per 1 cm/s decrease, 95% CI 2.56-9.09, P < 0.0001. In bootstrap validation, the final model generated an optimism-corrected area under the curve (AUC) almost identical to the value obtained using original data (0.947). In ROC analysis, while deceleration time, MCF, E/A ratio, and VMR predicted ATTR-CA with AUCs ranging 0.6-0.8, the average tissue Doppler mitral annular S' was the strongest predictor with an AUC 0.95, P < 0.0001 ( Figure 1B) . Dichotomizing the average mitral annular S' around the population median of < _6 vs. >6 cm/s was 100% sensitive but only 57% specific for ATTR-CA by 99m Tc-PYP scan. It should be noted that five patients who had a positive 99m Tc-PYP scan who met formal diagnostic criteria for ATTR-CA also had an abnormal monoclonal protein by international consensus criteria. 19 Of these, two had a known lymphoproliferative disorder, e.g. monoclonal gammopathy of undetermined significance based on bone marrow biopsy and were followed by a haematologist. All five patients ultimately chose not to undergo tissue biopsy to rule out the possibility of AL CA.
Discussion
This prospective cohort study is the first to report: (i) a 16% prevalence of ATTR-CA in elderly patients undergoing TAVR, (ii) an echocardiographic phenotype of low-flow low-gradient AS with reduced LVEF and severe diastolic dysfunction in this patient population, and (iii) reduced myocardial systolic mechanics with average tissue Doppler mitral annular S' independently associated with ATTR-CA.
Implications for severe as
The 16% prevalence of ATTR-CA that we report corroborates the 6-12% reported in smaller retrospective studies in patients with severe AS. 25, 26 The slightly higher prevalence is likely because our study population was older and exclusively underwent TAVR, not surgical Tissue Doppler and strain systolic function Average mitral annular S', cm/s 6.2 ± 1.7 6.6 ± 1. Unveiling TTR cardiac amyloidosis and its predictors among patients undergoing TAVR Figure 3 Speckle-strain imaging in elderly patients with severe symptomatic AS with and without ATTR-CA. Bullseye plots demonstrate relative apical sparing is the same whether amyloid is present or not. AS, aortic stenosis; ATTR-CA, transthyretin cardiac amyloidosis. among 146 patients who underwent surgical AVR, the presence of ATTR-CA was associated with death with a hazard ratio of 9.5 (95% CI 2.5-35.8, P = 0.001). 26 In a retrospective study of 171 patients with ATTR-CA with and without AS, mortality was the same irrespective of AVR, suggesting that ATTR-CA may have a deleterious contribution to outcomes. 28 Whether ATTR-CA affects mortality synergistically with severe AS or as the primary driver needs further exploration in large cohorts. The current study also suggests that 99m
Tc-PYP cardiac imaging can be used to screen for ATTR-CA in at risk populations. In Europe, Tc-DPD cardiac imaging has proven to be an effective screening tool for ATTR-CA, both among patients undergoing TAVR and HFpEF. 25, 27 Screening for ATTR-CA may identify ATTR-CA early in the setting of severe AS and/or HFpEF when emerging therapies may have greater benefit. Our data suggest that echocardiography may be an initial screen for ATTR-CA in this high risk, older population, with severe calcific AS. Patients diagnosed with ATTR-CA had specific features including male sex, concentric LV hypertrophy, severe diastolic dysfunction, and reduced myocardial mechanics ( Figure 4) . One would expect a Stage D3 low-flow AS with a preserved LVEF phenotype initially in patients with both AS and ATTR-CA that transitions to Stage D2 low-flow low-gradient AS with a low LVEF as systolic dysfunction ensues. The best independent echocardiographic predictor of ATTR-CA was an average mitral annular S' < _6 cm/s. The high sensitivity (100%) of a low mitral annular S < _6 cm/s may enable clinicians to rule out ATTR-CA in subjects with velocities >6 and consider further testing with 99m
Tc-PYP cardiac imaging in the rest. While endomyocardial biopsy and tissue typing with histological staining and precursor protein confirmation using mass spectrometry remain the gold standard for diagnosis of ATTR-CA, 29 these procedures often delay diagnosis and may not be appropriate in frail elderly adults, including those already undergoing TAVR. A positive radioisotope scan, such as 99m
Tc-PYP, in the absence of an abnormal monoclonal protein is 100% specific for ATTR-CA without the need for invasive heart biopsy. Furthermore, Tc-PYP cardiac imaging may have prognostic in addition to diagnostic importance in patients with ATTR-CA. 18 Potential mechanism of non-apical sparing in concomitant severe as and amyloid
Speckle strain imaging has demonstrated impaired LS at the base and mid LV with sparing of the apical segments as a predictive feature of cardiac amyloidosis. 13 Cardiac magnetic resonance imaging data have demonstrated that the base and mid-LV segments are twice as thick in amyloid compared with non-amyloid controls, whereas apical thickness only increased by 26%. 13 The apical sparing phenotype in ATTR-CA may reflect lower extracellular amyloid deposition at the apex, less resistance to myocardial deformation, and increased myocyte contraction relative to the other segments. In our cohort of patients with concomitant severe, symptomatic AS and ATTR-CA, apical sparing by speckle strain could not predict ATTR-CA. It is possible that the stress and afterload imposed on the ventricle by a severely calcified and stenotic aortic valve masks the sparing of apical strain that is otherwise detected in a patient with pure ATTR-CA without AS.
Limitations
This study was subject to the referral bias of an academic medical centre. Strain analysis was not performed universally as it could only be obtained in patients with adequate endocardial wall definition. While all patients underwent a 99m
Tc-PYP scan, cardiac biopsy was not performed given safety risks in this frail older population already undergoing TAVR. However, Tc-PYP is an excellent test for diagnosing advanced forms of ATTR-CA and may replace the need for endomyocardial biopsy. 19 In the current study, of the five patients with ATTR-CA who had an abnormal monoclonal protein, two met the formal diagnostic criteria and had a known MGUS, but ultimately all five chose not to undergo tissue biopsy to formally rule out AL cardiac amyloidosis. The diagnostic utility of 99m
Tc-PYP cardiac imaging in early disease has not yet been studied, raising the possibility that ATTR-CA could have been missed among severe AS patients with early cardiac amyloidosis.
Conclusions
In this study of elderly patients with severe calcific AS undergoing TAVR, ATTR cardiac amyloidosis was prevalent at a rate of 16% and associated with a phenotype of low-flow, low gradient AS with a reduced LVEF. An average tissue Doppler mitral annular S' of 6 cm/s or lower may be a sensitive measure that should prompt a confirmatory 
